Table 2.
Unadjusted Analysis of Urbanicity and Working Experience in Attitudes Toward HPV Characteristics, and Future Promotion Plan of the HPV Vaccine.
| Urbanicity |
Work length |
||||||
|---|---|---|---|---|---|---|---|
| Urban | Suburban | P-valuea | <5 years | 6-10 years | ≥11 years | P-valuea | |
| HPV is sexually transmitted | 4.64 ± 0.10 | 4.74 ± 0.06 | .2904 | 4.81 ± 0.07 | 4.73 ± 0.10 | 4.55 ± 0.08 | .0231 |
| HPV causes cervical cancer | 4.83 ± 0.05 | 4.79 ± 0.05 | .6324 | 4.87 ± 0.06 | 4.80 ± 0.07 | 4.70 ± 0.06 | .1485 |
| HPV cause cancers other than cervical cancer | 4.47 ± 0.13 | 4.42 ± 0.11 | .6347 | 4.62 ± 0.12 | 4.40 ± 0.13 | 4.22 ± 0.14 | .1057 |
| Ideal age to initiate vaccination | 15.75 ± 0.93 | 17.54 ± 0.72 | .0966 | 17.07 ± 0.71 | 17.49 ± 1.08 | 16.30 ± 0.98 | .4034 |
| Make the HPV vaccine available for males | 4.28 ± 0.15 | 4.44 ± 0.09 | .4333 | 4.43 ± 0.12 | 4.43 ± 0.10 | 4.30 ± 0.12 | .7519 |
| Make the HPV vaccine an EPI vaccine | 4.33 ± 0.12 | 4.58 ± 0.08 | .0315 | 4.57 ± 0.09 | 4.58 ± 0.10 | 4.33 ± 0.11 | .0934 |
a
From Kruskal-Wallis Test.